
|Articles|February 15, 2004
Experience underlines efficacy of full-time occlusion for amblyopia
Anaheim, CA-Outcomes from experience spanning more than 30 years and involving hundreds of patients indicate that full-time occlusion is a highly safe and effective method for treating amblyopia and accomplishing the goal of obtaining equal visual acuity, said William E. Scott, MD, in the fourth annual Marshall M. Parks Lecture at the annual meeting of the American Academy of Ophthalmology.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA grants IDE approval to EyeYon Medical for its US clinical study of EndoArt
2
Ocular Therapeutix accelerates NDA submission plans for AXPAXLI for wet AMD
3
First patient treated in ViaLase’s IDE trial
4
Formosa Pharmaceuticals and Rxilient sign licensing and commercialization agreement for APP13007
5















































.png)


